Free Access
| Issue |
Biologie Aujourd'hui
Volume 208, Number 3, 2014
|
|
|---|---|---|
| Page(s) | 207 - 209 | |
| Section | Régulation de la pression artérielle | |
| DOI | https://doi.org/10.1051/jbio/2014024 | |
| Published online | 5 décembre 2014 | |
- ALLHAT Officers and Coordinators for the ALLHAT Research Group., Major outcomes in high-risk hypertensive patients randomized to angiotensin-converting enzyme inhibitor or calcium channel blocker vs diuretic: The Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT). JAMA, 2000, 288, 2981–2997. [Google Scholar]
- Freis E., Veterans Administration Cooperative study Group on antihypertensive agents. Effects of treatment on morbidity in hypertension. JAMA, 1967, 202, 116–122. [CrossRef] [PubMed] [Google Scholar]
- Gao J., Marc Y., Leroux V., Balavoine F., Llorens-Cortes C., A new strategy for treating hypertension by blocking the activity of the brain renin-angiotensin system with aminopeptidase A inhibitors. Clin Sci (London), 2014, 127, 135–148. [Google Scholar]
- Laurent S., Schlaich M., Esler M., New drugs, procedures, and devices for hypertension. Lancet, 2012, 380, 591–600. [CrossRef] [PubMed] [Google Scholar]
- Lifton R.P., Genetic determinants of human hypertension. Proc Natl Acad Sci USA, 1955, 92, 8545–8551. [CrossRef] [Google Scholar]
- Louis-Dit-Picard H, Barc J, Trujillano D, Miserey-Lenkei S, Bouatia-Naji N, Pylypenko O, Beaurain G, Bonnefond A, Sand O, Simian C, Vidal-Petiot E, Soukaseum C, Mandet C, Broux F, Chabre O, Delahousse M, Esnault V, Fiquet B, Houillier P, Bagnis CI, Koenig J, Konrad M, Landais P, Mourani C, Niaudet P, Probst V, Thauvin C, Unwin RJ, Soroka SD, Ehret G, Ossowski S, Caulfield M; International Consortium for Blood Pressure (ICBP), Bruneval P, Estivill X, Froguel P, Hadchouel J, Schott JJ, Jeunemaitre X, KLHL3 mutations cause familial hyperkalemic hypertension by impairing ion transport in the distal néphron. Nat Genet, 2012, 44, 456–460. [CrossRef] [PubMed] [Google Scholar]
- Ondetti M.A., Rubin B., Cushman D.W., Design of specific inhibitors of angiotensin-converting enzyme: new class of orally active antihypertensive agents. Science, 1977, 196, 441–444. [CrossRef] [PubMed] [Google Scholar]
- Paulis L., Steckeglins U.M., Unger T., Key advances in antihypertensive treatment. Nat Rev Cardiol, 2012, 9, 276–285. [CrossRef] [PubMed] [Google Scholar]
- Persu A., Sapoval M., Azizi M., Monge M., Danse E., Hammer F., Renkin J., Renal artery stenosis following renal denervation: a matter of concern. J Hypertens, 2014, 32, 2101–2105. [CrossRef] [Google Scholar]
- Sumners C., Horiuchi M., Widdop R.E., McCarthy C., Unger T., Steckelings. Protective arms of the renin-angiotensin-system in neurological diseases. Clin Exp Pharamacol Physiol, 2013, 40, 580–588. [CrossRef] [Google Scholar]
Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.
Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.
Initial download of the metrics may take a while.